 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Crystal structure of metallo-beta-lactamase imp-1 mutant (d81e)
|
|
Structure:
|
 |
Beta-lactamase imp-1. Chain: a, b, c, d. Synonym: imp-1 metallo-beta-lactamase, beta-lactamase, type ii, penicillinase, blaimp. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Serratia marcescens. Organism_taxid: 615. Strain: tn9106. Gene: blaimp-1. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
3.00Å
|
R-factor:
|
0.224
|
R-free:
|
0.295
|
|
|
Authors:
|
 |
Y.Yamaguchi,Y.Yamagata,M.Goto
|
Key ref:
|
 |
Y.Yamaguchi
et al.
(2005).
Probing the role of Asp-120(81) of metallo-beta-lactamase (IMP-1) by site-directed mutagenesis, kinetic studies, and X-ray crystallography.
J Biol Chem,
280,
20824-20832.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
08-Dec-04
|
Release date:
|
29-Mar-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P52699
(BLAB_SERMA) -
Beta-lactamase IMP-1
|
|
|
|
Seq: Struc:
|
 |
 |
 |
246 a.a.
217 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
response to antibiotic
|
2 terms
|
 |
|
Biochemical function
|
hydrolase activity
|
4 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
280:20824-20832
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Probing the role of Asp-120(81) of metallo-beta-lactamase (IMP-1) by site-directed mutagenesis, kinetic studies, and X-ray crystallography.
|
|
Y.Yamaguchi,
T.Kuroki,
H.Yasuzawa,
T.Higashi,
W.Jin,
A.Kawanami,
Y.Yamagata,
Y.Arakawa,
M.Goto,
H.Kurosaki.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Metallo-beta-lactamase IMP-1 is a di-Zn(II) metalloenzyme that efficiently
hydrolyzes beta-lactam antibiotics. Wild-type (WT) IMP-1 has a conserved
Asp-120(81) in the active site, which plays an important role in catalysis. To
probe the catalytic role of Asp-120(81) in IMP-1, the IMP-1 mutants, D120(81)A
and D120(81)E, were prepared by site-directed mutagenesis, and various kinetics
studies were conducted. The IMP-1 mutants exhibited 10(2)-10(4)-fold drops in
k(cat) values compared with WT despite the fact that they contained two Zn(II)
ions in the active site. To evaluate the acid-base characteristics of
Asp-120(81), the pH dependence for hydrolysis was examined by stopped-flow
studies. No observable pK(a) values between pH 5 and 9 were found for WT and
D120(81)A. The rapid mixing of equimolar amounts of nitrocefin and all enzymes
failed to result in the detection of an anion intermediate of nitrocefin at 650
nm. These results suggest that Asp-120(81) of IMP-1 is not a factor in
decreasing the pK(a) for the water bridging two Zn(II) ions and is not a proton
donor to the anionic intermediate. In the case of D120(81)E, the nitrocefin
hydrolysis product, which shows a maximum absorption at 460 nm, was bound to
D120(81)E in the protonated form. The three-dimensional structures of D120(81)A
and D120(81)E were also determined at 2.0 and 3.0 A resolutions, respectively.
In the case of D120(81)E, the Zn-Zn distance was increased by 0.3 A compared
with WT, due to the change in the coordination mode of Glu-120(81)OE1 and the
positional shift in the conserved His-263(197) at the active site.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
FIG. 1. Schematic representation of the active site of CcrA
(PDB code 1ZNB [PDB]
) from B. fragilis (28). The residues are labeled according to
the BBL standard numbering (20). The Zn(II) atoms are shown in
green, oxygen atoms in red, nitrogen atom in blue, and sulfur
atoms in yellow.
|
 |
Figure 6.
FIG. 6. Plots of relative activity of nitrocefin hydrolysis
by WT and the IMP-1 mutants D120(81)A and D120(81)E against the
concentrations of phosphate ion at 30 °C.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2005,
280,
20824-20832)
copyright 2005.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
P.Oelschlaeger,
N.Ai,
K.T.Duprez,
W.J.Welsh,
and
J.H.Toney
(2010).
Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?
|
| |
J Med Chem, 53,
3013-3027.
|
 |
|
|
|
|
 |
J.Momb,
C.Wang,
D.Liu,
P.W.Thomas,
G.A.Petsko,
H.Guo,
D.Ringe,
and
W.Fast
(2008).
Mechanism of the quorum-quenching lactonase (AiiA) from Bacillus thuringiensis. 2. Substrate modeling and active site mutations.
|
| |
Biochemistry, 47,
7715-7725.
|
 |
|
|
|
|
 |
M.Dal Peraro,
A.J.Vila,
P.Carloni,
and
M.L.Klein
(2007).
Role of zinc content on the catalytic efficiency of B1 metallo beta-lactamases.
|
| |
J Am Chem Soc, 129,
2808-2816.
|
 |
|
|
|
|
 |
G.Estiu,
D.Suárez,
and
K.M.Merz
(2006).
Quantum mechanical and molecular dynamics simulations of ureases and Zn beta-lactamases.
|
| |
J Comput Chem, 27,
1240-1262.
|
 |
|
|
|
|
 |
J.Spencer,
and
T.R.Walsh
(2006).
A new approach to the inhibition of metallo-beta-lactamases.
|
| |
Angew Chem Int Ed Engl, 45,
1022-1026.
|
 |
|
|
|
|
 |
L.Lagartera,
A.González,
J.A.Hermoso,
J.L.Saíz,
P.García,
J.L.García,
and
M.Menéndez
(2005).
Pneumococcal phosphorylcholine esterase, Pce, contains a metal binuclear center that is essential for substrate binding and catalysis.
|
| |
Protein Sci, 14,
3013-3024.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|